First-in-human studies of safety, tolerability, pharmacokinetics, and pharmacodynamics of SAR443820, a centrally penetrant RIPK1 inhibitor in healthy participants
MUSCLE & NERVE(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MUSCLE & NERVE(2022)